SynthesisBMJ (Clinical research ed.)2023
Prevalence and predictors of data and code sharing in the medical and health sciences: systematic review with meta-analysis of individual participant data.
Synthesis in BMJ (Clinical research ed.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- AI-assisted scoping review of code sharing in clinical prediction model research.Nature medicine · 2026Article
- Open Science Policies and Practices Among Medical Journals.JAMA network open · 2026Article
- Who Funds Open Data Sharing? Analysis of data availability statements in biomedical publications.bioRxiv : the preprint server for biology · 2026Article
- Evaluating the reproducibility and verifiability of nutrition research: a case study of studies assessing the relationship between potatoes and colorectal cancer.Nutrition & diabetes · 2026Review
- Evaluation of the replicability of systematic reviews with meta-analyses of the effects of health interventions.Research synthesis methods · 2026Article
- Individual participant data meta-analysis tips and tricks: troubleshooting commonly encountered issues of contacting trialists for individual participant data.JBI evidence synthesis · 2026Article
- Data sharing in acupuncture meta-analyses: Associations with journal policies and practical considerations.Integrative medicine research · 2026Article
- Why can't epidemiology be automated (yet)?International journal of epidemiology · 2026Article
- An assessment of data and code sharing in research funded by the Nathan Shock Centers, 2017-2022: a meta-research study.Innovation in aging · 2026Article
- Measurement reliability, construct validity, and transparent reporting in original and replication psychological research.PloS one · 2026Article
- Article
- Home-based treatment for patients with hematological cancer in Denmark-A national overview.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Improving reproducibility of data analysis and code in medical research: 5 recommendations to get started.BMJ open · 2025Review
- Risk of bias and low reproducibility in meta-analytic evidence from fast-tracked publications during the coronavirus disease 2019 pandemic.PNAS nexus · 2025Article
- Six solutions for clinical study data sharing in Germany.BMC medical research methodology · 2025Article
- The State of Data Sharing in Plastic Surgery: An Analysis of Journal Practices and Author Adherence.Plastic and reconstructive surgery. Global open · 2025Article
- Transparency, Reproducibility, and Accessibility of Clinical and Experimental Studies in Allergy (TRACES): Study design and protocol.The journal of allergy and clinical immunology. Global · 2025Article
- Open science interventions to improve reproducibility and replicability of research: a scoping review.Royal Society open science · 2025Article
- How Transparent and Reproducible Are Studies That Use Animal Models of Opioid Addiction?Addiction biology · 2025Article
- Systematic Review: AI Applications in Liver Imaging with a Focus on Segmentation and Detection.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo synthesise research investigating data and code sharing in medicine and health to establish an accurate representation of the prevalence of sharing, how this frequency has changed over time, and what factors influence availability.
designSystematic review with meta-analysis of individual participant data. DATA SOURCES: Ovid Medline, Ovid Embase, and the preprint servers medRxiv, bioRxiv, and MetaArXiv were searched from inception to 1 July 2021. Forward citation searches were also performed on 30 August 2022. REVIEW
methodsMeta-research studies that investigated data or code sharing across a sample of scientific articles presenting original medical and health research were identified. Two authors screened records, assessed the risk of bias, and extracted summary data from study reports when individual participant data could not be retrieved. Key outcomes of interest were the prevalence of statements that declared that data or code were publicly or privately available (declared availability) and the success rates of retrieving these products (actual availability). The associations between data and code availability and several factors (eg, journal policy, type of data, trial design, and human participants) were also examined. A two stage approach to meta-analysis of individual participant data was performed, with proportions and risk ratios pooled with the Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis.
resultsThe review included 105 meta-research studies examining 2 121 580 articles across 31 specialties. Eligible studies examined a median of 195 primary articles (interquartile range 113-475), with a median publication year of 2015 (interquartile range 2012-2018). Only eight studies (8%) were classified as having a low risk of bias. Meta-analyses showed a prevalence of declared and actual public data availability of 8% (95% confidence interval 5% to 11%) and 2% (1% to 3%), respectively, between 2016 and 2021. For public code sharing, both the prevalence of declared and actual availability were estimated to be <0.5% since 2016. Meta-regressions indicated that only declared public data sharing prevalence estimates have increased over time. Compliance with mandatory data sharing policies ranged from 0% to 100% across journals and varied by type of data. In contrast, success in privately obtaining data and code from authors historically ranged between 0% and 37% and 0% and 23%, respectively.
conclusionsThe review found that public code sharing was persistently low across medical research. Declarations of data sharing were also low, increasing over time, but did not always correspond to actual sharing of data. The effectiveness of mandatory data sharing policies varied substantially by journal and type of data, a finding that might be informative for policy makers when designing policies and allocating resources to audit compliance. SYSTEMATIC REVIEW REGISTRATION: Open Science Framework doi:10.17605/OSF.IO/7SX8U.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.